COR Cencora Inc.

  1. Stocks
  2. Healthcare
  3. NYSE: COR

Price (delayed)

$240.08

Market cap

$47.89B

P/E Ratio

25.87

Dividend/share

$1.99

EPS

$9.28

Enterprise value

$49.8B

amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in ...

Highlights
The equity has soared by 75% from the previous quarter
The company's debt fell by 15% YoY
COR's P/E is 19% above its last 4 quarters average of 21.6
The company's gross margin fell by 2.9% YoY
Sector: Healthcare
Industry: Medical Distribution
Website: https://www.amerisourcebergen.com/
Peers: EQIX OLP STWD ALX

Key stats

What are the main financial stats of COR
Market
Shares outstanding
199.48M
Market cap
$47.89B
Enterprise value
$49.8B
Valuations
Price to earnings (P/E)
25.87
Price to book (P/B)
52.85
Price to sales (P/S)
0.18
EV/EBIT
19.29
EV/EBITDA
16.54
EV/Sales
0.18
Earnings
Revenue
$271.58B
EBIT
$2.58B
EBITDA
$3.01B
Free cash flow
$3.63B
Per share
EPS
$9.28
Free cash flow per share
$18.14
Book value per share
$4.54
Revenue per share
$1,357.35
TBVPS
$253.16
Balance sheet
Total assets
$64.69B
Total liabilities
$63.63B
Debt
$4.78B
Equity
$911.7M
Working capital
-$5.91B
Liquidity
Debt to equity
5.24
Current ratio
0.88
Quick ratio
0.48
Net debt/EBITDA
0.63
Margins
EBITDA margin
1.1%
Gross margin
3.4%
Net margin
0.7%
Operating margin
0.9%
Efficiency
Return on assets
3%
Return on equity
311%
Return on invested capital
104.6%
Return on capital employed
18.6%
Return on sales
1%
Dividend
Dividend yield
0.83%
DPS
$1.99
Payout ratio
21.4%

COR stock price

How has the Cencora stock price performed over time
Intraday
0.9%
1 week
1.17%
1 month
-0.82%
1 year
42.83%
YTD
16.9%
QTD
-1.2%

Financial performance

How have Cencora's revenue and profit performed over time
Revenue
$271.58B
Gross profit
$9.28B
Operating income
$2.53B
Net income
$1.87B
Gross margin
3.4%
Net margin
0.7%
Cencora's revenue has increased by 12% YoY and by 3.6% QoQ
COR's gross profit is up by 11% year-on-year and by 3.6% since the previous quarter
Cencora's operating margin has decreased by 10% YoY
The operating income has grown by 8% from the previous quarter and by 7% YoY

Growth

What is Cencora's growth rate over time

Valuation

What is Cencora stock price valuation
COR P/E details
P/E
25.87
P/B
52.85
P/S
0.18
EV/EBIT
19.29
EV/EBITDA
16.54
EV/Sales
0.18
COR's P/E is 19% above its last 4 quarters average of 21.6
COR's EPS is up by 11% year-on-year and by 8% since the previous quarter
The equity has soared by 75% from the previous quarter
The price to book (P/B) is 27% lower than the last 4 quarters average of 71.7
The P/S is 80% above the 5-year quarterly average of 0.1 and 80% above the last 4 quarters average of 0.1
Cencora's revenue has increased by 12% YoY and by 3.6% QoQ

Efficiency

How efficient is Cencora business performance
The ROE has dropped by 83% year-on-year and by 42% since the previous quarter
Cencora's ROIC has soared by 59% YoY and by 32% from the previous quarter
COR's return on sales is up by 11% since the previous quarter
The company's return on assets rose by 3.4% QoQ

Dividends

What is COR's dividend history
Dividend details
DPS
$1.99
Dividend yield
0.83%
Payout ratio
21.4%
Recent dividends

Financial health

How did Cencora financials performed over time
COR's total assets is up by 12% year-on-year and by 3.4% since the previous quarter
Cencora's total liabilities has increased by 10% YoY and by 2.8% from the previous quarter
The debt to equity has soared by 117% year-on-year but it has declined by 43% since the previous quarter
The equity has soared by 75% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.